Characterization of VNFG, the delta  Subunit of the vnf-Encoded Apodinitrogenase from Azotobacter vinelandii
IMPLICATIONS FOR ITS ROLE IN THE FORMATION OF FUNCTIONAL DINITROGENASE 2*

(Received for publication, August 30, 1996, and in revised form, November 13, 1996)

Ranjini Chatterjee , Paul W. Ludden Dagger and Vinod K. Shah §

From the Department of Biochemistry and Center for the Study of Nitrogen Fixation, College of Agricultural and Life Sciences, University of Wisconsin, Madison, Wisconsin 53706

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
CONCLUSIONS
FOOTNOTES
Acknowledgments
REFERENCES


ABSTRACT

The vnf-encoded apodinitrogenase (apodinitrogenase 2) from Azotobacter vinelandii is an alpha 2beta 2delta 2 hexamer. The delta  subunit (the VNFG protein) has been characterized in order to further delineate its function in the nitrogenase 2 enzyme system. Two species of VNFG were observed in cell-free extracts resolved on anoxic native gels; one is composed of VNFG associated with the VNFDK polypeptides, and the other is a homodimer of the VNFG protein. Both species of VNFG are observed in extracts of A. vinelandii strains that accumulate dinitrogenase 2, whereas extracts of strains impaired in the biosynthetic pathway of the iron-vanadium cofactor (FeV-co) that accumulate apodinitrogenase 2 (a catalytically inactive form of dinitrogenase 2 that lacks FeV-co) exhibit only the VNFG dimer on native gels. FeV-co and nucleotide are required for the stable association of VNFG with the VNFDK polypeptides; this stable association can be correlated with the formation of active dinitrogenase 2. The iron-molybdenum cofactor was unable to replace FeV-co in promoting the stable association of VNFG with VNFDK. FeV-co specifically associates with the VNFG dimer in vitro to form a complex of unknown stoichiometry; combination of this VNFG-FeV-co species with apodinitrogenase 2 results in its reconstitution to dinitrogenase 2. The results presented here suggest that VNFG is required for processing apodinitrogenase 2 to functional dinitrogenase 2.


INTRODUCTION

The biological reduction of atmospheric N2 to NH4+ occurs via any one of three genetically distinct nitrogenase enzymes in the aerobe Azotobacter vinelandii (for reviews, see Refs. 1 and 2). Expression of the three nitrogenase enzymes, designated nitrogenase 1, 2, and 3, is regulated by the metal content of the growth medium (3). Nitrogenase 1, a molybdenum (Mo)-containing enzyme, is synthesized in medium containing Mo, while nitrogenases 2 and 3 are repressed by molybdenum. Nitrogenase 2, a vanadium (V)-containing enzyme, is expressed in the absence of molybdenum in medium containing vanadium, expression of nitrogenase 3 (containing only iron) requires medium depleted in both molybdenum and vanadium. Nitrogenases 1, 2, and 3 are encoded by the nif, vnf, and anf operons, respectively; certain nif gene products are necessary for the function of the molybdenum-independent nitrogenases (4-6).

All three nitrogenase enzymes are oxygen-labile iron-sulfur proteins comprising two components, dinitrogenase and dinitrogenase reductase. Dinitrogenase contains the active site cofactor of the enzyme, and dinitrogenase reductase serves as the obligate electron donor to dinitrogenase during catalysis in a MgATP- and reductant-dependent process (7, 8). In addition to reducing N2, all three nitrogenase enzymes reduce C2H2 and H+ (9).

The component proteins of nitrogenase 2 have been purified from both A. vinelandii and Azotobacter chroococcum (10-14). Dinitrogenase 2 contains an iron-vanadium cofactor (FeV-co)1 similar to the iron-molybdenum cofactor (FeMo-co) of nitrogenase 1 at the active site (15), and P clusters that are spectroscopically identical to those of dinitrogenase 1 (16). Although the biosynthetic pathway of FeMo-co and the processing of the component proteins of nitrogenase 1 to catalytically active forms are well documented (for review, see Ref. 17), steps in the biosynthesis of the cofactors of nitrogenases 2 and 3 and in the maturation of their component proteins remain uncharacterized.

Certain features of the Mo-independent nitrogenases distinguish them from nitrogenase 1. The formation of C2H6 (in addition to C2H4) as a minor product of C2H2 reduction is a characteristic of nitrogenase 2 and 3; in fact, C2H6 formation is often taken as indicative of the presence of a Mo-independent nitrogenase (18). Most relevant to this investigation, dinitrogenases 2 and 3 contain an additional subunit, delta , encoded by vnfG and anfG, respectively (19-21), compared to the alpha 2beta 2 structure of the nif-encoded dinitrogenase 1. Kim and Rees (22) suggested that the delta  subunits might be involved in stabilization of the quaternary structures of dinitrogenases 2 and 3; subsequent studies, however, illustrated more intriguing functions for the delta  subunits of dinitrogenase 2 and 3. Waugh et al. (23) demonstrated that VNFG and ANFG were required for diazotrophic growth by A. vinelandii but not for C2H2 reduction. Recently, VNFG was shown to be required to convert apodinitrogenase 2 (in the presence of FeV-co) to a form capable of substrate reduction (24); the requirement for VNFG could occur in the processing of apodinitrogenase 2 to dinitrogenase 2, or in catalysis by the newly formed holodinitrogenase 2 (24). The role of VNFG and ANFG might be analogous to the function of the gamma  protein in processing nif-encoded apodinitrogenase 1 (dinitrogenase 1 that does not contain FeMo-co) to dinitrogenase 1. The form of apodinitrogenase 1 that is activable by FeMo-co has an alpha 2beta 2gamma 2 composition (25); the gamma  protein, a non-nif-encoded gene product, has been shown to specifically associate with FeMo-co and perhaps function as a chaperone-insertase in the maturation of apodinitrogenase 1 to dinitrogenase 1 (26).

In this report, we describe the characterization of VNFG (the delta  subunit of apodinitrogenase 2) and present results that indicate a role for VNFG in the processing of apodinitrogenase 2 to dinitrogenase 2.


EXPERIMENTAL PROCEDURES

Materials

All reagents used for A. vinelandii growth media were of analytical grade or higher purity. Sodium metavanadate (NaVO3, 99.995% in purity), Tris base, and glycine were purchased from Fisher. Sodium dithionite (DTH) was from Fluka Chemicals. DEAE-cellulose was a Whatman DE-52 product. Octyl-Sepharose CL-4B, Sephadex G-25, and the Superose 12 gel filtration column were from Pharmacia Biotech, Inc. Nitrocellulose membrane and acrylamide/bis solution were from Bio-Rad. Citric acid was obtained from Mallinckrodt. All other chemicals were from Sigma. The fast protein liquid chromatography system was a LKB instrument.

A. vinelandii Strains and Growth Conditions

A. vinelandii strains UW45 (nifB-; Ref. 27), CA12 (Delta nifHDK; Ref. 28), CA11.1 (Delta nifHDKvnfDGK1::spc; Ref. 23), CA119 (vnfG, Cys-17 right-arrow stop; Ref. 23), CA117.30 (Delta nifDKB; Ref. 24), DJ42.48 (Delta nifENXvnfE; Ref. 29), CA11.80 (Delta nifHDKvnfH; Ref. 19), and CA11.6.82 (W-tolerant, vnfD82::Tn5-B21Delta nifHDKrifr; Ref. 30) have been described. Strains were grown in Burk's medium prepared in deionized water; all vessels used in preparing media and for cell culture were rinsed thoroughly in 4 N HCl and then in deionized water. Strains CA12, CA11.1, CA119, CA117.30, DJ42.48, CA11.80, and CA11.6.82 were grown in Burk's medium that lacked sodium molybdate and contained 10 µM NaVO3 for derepression of the vnf system. Cultures of CA12, CA119, and CA117.30 (15 liters) were grown in 20-liter polycarbonate carboys with vigorous aeration at 30 °C in Burk's medium containing 40 µg of nitrogen/ml as ammonium acetate; the cultures were monitored for depletion of ammonium, following which they were derepressed for 4 h. The cells were concentrated using a Pellicon cassette system equipped with a filtration membrane (0.45 µM, Millipore Corp., Bedford, MA) and were centrifuged. The cell pellets were frozen in liquid N2 and stored at -80 °C. Strains CA11.1, DJ42.48, CA11.80, and CA11.6.82 were grown in 250-ml cultures; cells were concentrated by centrifugation at 10,000 rpm for 10 min, and derepression was initiated for 4 h by suspending the cell pellets in nitrogen-free Burk's medium. Cells were harvested by centrifugation and were frozen as described above.

Strain UW45 was grown and derepressed on tungsten-containing medium (molybdenum-free) as described previously (31). For derepression of the nif system, strains were grown on Mo-containing medium as described previously (32). Cell-free extracts of all A. vinelandii strains were prepared by the osmotic shock method (32). When necessary, small molecules were removed from the extracts by Sephadex G-25 gel-filtration chromatography.

Buffer Preparation

All buffers were sparged with purified N2 (and degassed on a gassing manifold where appropriate) for 10-30 min, and DTH was added to a final concentration of 1.7 mM. All buffers used in column chromatography contained 0.2 mM phenylmethylsulfonyl fluoride and 0.5 µg/ml leupeptin. Buffers used in fast protein liquid chromatography were filtered through a 0.45 µM filter. Tris-HCl used was at pH 7.4 unless indicated otherwise.

Electrophoresis

The procedure for SDS-PAGE has been described (33); all SDS gels were 15% acrylamide (0.39% bisacrylamide). Proteins being analyzed by anoxic native gel electrophoresis were resolved on 7-14% acrylamide (37.5:1, acrylamide:bisacrylamide) and 0-20% sucrose gradient gels at 4 °C; 65 mM Tris-glycine (pH 8.5) sparged with N2 and containing 1.7 mM DTH was used as the electrophoresis buffer. Gels were prerun for at least 60 min at 120 V for initial reduction, and proteins were electrophoresed for approximately 1900 V × h (at 120 V). Unless indicated otherwise, all samples applied onto the gel contained 8% glycerol.

Antibodies and Immunoblot Analysis

VNFG (the delta  protein) was separated from the alpha 2beta 2delta 2 apodinitrogenase 2 hexamer by SDS-PAGE. The pure VNFG protein was extracted from the gel and injected into rabbits to produce polyclonal antibodies at the Animal Care Unit of the University of Wisconsin-Madison Medical School. Antibodies to VNFDK (the alpha  and beta  polypeptides of dinitrogenase 2) were produced similarly. Immunoblot analysis was performed as described by Brandner et al. (34).

Partial Purification of Dinitrogenase 2 and Apodinitrogenase 2

Dinitrogenase 2 was partially purified from A. vinelandii strain CA119 (vnfG, Cys-17 right-arrow stop) by DEAE-cellulose chromatography, followed by heat treatment as described by Hales et al. (11). Partially purified dinitrogenase 2 was concentrated by ultrafiltration using a XM100-A membrane. Partial purification of apodinitrogenase 2 from A. vinelandii strain CA117.30 (Delta nifDKB) was performed through the octyl-Sepharose chromatography step as described previously (24).

Preparation of FeV-co and FeMo-co

A preparation of FeV-co was made by the citric acid treatment of partially purified dinitrogenase 2 with modifications to the method described previously (24). In a typical reaction, 0.4 ml of a solution of 0.4 M citric acid (made anoxic by diluting a 2.0 M stock solution into N2-sparged water containing 1.7 mM DTH) was added to 2 ml (31.2 mg of protein) of dinitrogenase 2 (partially purified from A. vinelandii strain CA119 (vnfG, Cys-17 right-arrow stop) in a screw-capped centrifuge tube (Beckman) fitted with rubber-stoppered inserts to allow evacuation and flushing on a gassing manifold. The solution was mixed thoroughly using a Vortex mixer and incubated on ice for 10 min, following which it was centrifuged at 10,000 rpm for 5 min. The supernatant was discarded, and the pellet was suspended in 4 ml of 0.025 M Tris-HCl. This suspension of acid-denatured dinitrogenase 2 was centrifuged at 10,000 rpm for 20 min, and the supernatant (hereafter referred to as FeV-co) was used as a source of FeV-co in the in vitro activation of apodinitrogenase 2 by the cofactor. Purified FeMo-co was prepared by the method of Shah and Brill (32); when it was necessary to avoid any denaturing effects of N-methylformamide (NMF), FeMo-co was prepared by the citric acid treatment of dinitrogenase 1 as described by Allen et al. (35).

Activation of Apodinitrogenase 2 by FeV-co (FeV-co Insertion Assay)

The assay consists of two steps; in the first step, apodinitrogenase 2 is activated by FeV-co to form holodinitrogenase 2, and in the second step, the C2H2 reduction activity of the newly formed holodinitrogenase 2 is monitored. Reactions to be analyzed by native PAGE were only taken through the first phase of the assay (FeV-co insertion). Nine-ml rubber-stoppered serum vials were repeatedly evacuated and flushed with argon and rinsed with 0.3 ml of 0.025 M Tris-HCl (containing 1.7 mM DTH). The following components were added to the vials in the order indicated: 200 µl (4 mg of protein) of the appropriate cell-free extract or partially purified apodinitrogenase 2 (0.2 mg of protein), 200 µl of an anoxic solution of 50% glycerol (containing 1.7 mM DTH), 200 µl of a solution of FeV-co, and 200 µl of an ATP-regenerating mixture (containing 3.6 mM ATP, 6.3 mM MgCl2, 51 mM creatine phosphate, 20 units/ml creatine phosphokinase, and 6.3 mM DTH in 0.025 M Tris-HCl, pH 8.0). The reaction-mixtures were incubated at room temperature for 20 min, and samples to be applied onto the native gels were placed on ice. The activity of the newly formed dinitrogenase 2 in the remaining vials was determined by the C2H2 reduction assay for nitrogenase (31) as follows: 800 µl of the ATP-regenerating mixture and 10 µl (0.1 mg of protein) of dinitrogenase reductase 1 were added to the vials, which were then brought to atmospheric pressure. C2H2 reduction was initiated by the addition of 0.5 ml of C2H2 to the vials; following a 30-min incubation at 30 °C in a rotary water-bath shaker, the reactions were terminated by the addition of 0.1 ml of 4 N NaOH.

When testing the requirement for a particular component in the FeV-co insertion assay, the given component was excluded and an equal volume of 0.025 M Tris-HCl was added. FeMo-co was added to the reactions (in place of FeV-co) as 40 µl of purified FeMo-co in NMF, or as 50 µl of acid-denatured dinitrogenase 1. Certain reactions contained FeV-co that had been air-oxidized. Reactions testing the requirement for dinitrogenase reductase contained either 40 µl (0.4 mg of protein) of purified dinitrogenase reductase 1, or 40 µl (0.1 mg of protein) of partially purified dinitrogenase reductase 2. Nucleotide (other than ATP) solutions contained the following: 15 mM XTP (or XDP), 30 mM MgCl2, and 6.3 mM DTH in 0.025 M Tris-HCl, pH 8.0; 200 µl of the appropriate nucleotide solution was added to certain reaction-mixtures in place of the ATP-regenerating solution. The final XTP (or XDP) concentration (other than ATP, which was added in the form of the ATP-regenerating mixture) in the FeV-co insertion reactions was 3.75 mM. When testing various cell-free extracts as a source of FeV-co, 200 µl of the appropriate extract (~3.6 mg of protein) was added to the reactions in place of acid-denatured dinitrogenase 2.

Molecular Mass Determination

A Superose 12 column (Vo = 8.5 ml) used in conjunction with a LKB fast protein liquid chromatography system, was calibrated using bovine serum albumin (67 kDa), ovalbumin (45 kDa), myoglobin (18 kDa), and cytochrome c (12.5 kDa). Two hundred µl of partially purified apodinitrogenase 2 (6.7 mg of protein) were applied to the Superose 12 column that had been equilibrated in buffer containing 0.1 M NaCl in 0.025 M Tris-HCl. The column was developed with the same buffer, and fractions (0.5 ml), collected anoxically, were monitored for VNFG (the delta  protein) by SDS-PAGE and anoxic native PAGE.

Protein Determination

Protein concentrations of cell-free extracts and partially purified protein fractions were determined by the bicinchoninic acid method (36).

Association of FeV-co with VNFG (the delta  Protein)

The interaction between FeV-co (in the form of acid-denatured dinitrogenase 2) and VNFG was monitored using the Superose 12 gel-filtration column (used in conjunction with a LKB fast protein liquid chromatography system). Two hundred µl of a solution of FeV-co were applied to the Superose 12 column (equilibrated in buffer containing 0.1 M NaCl in 0.025 M Tris-HCl); the column was eluted with the same buffer, and fractions (0.5 ml, collected anoxically) were tested for FeV-co using the FeV-co insertion assay. Two hundred µl (0.8 mg of protein) of a fraction containing VNFG that contained no VNFDK or FeV-co (and therefore exhibited no activity in the FeV-co insertion assay) were chromatographed on the Superose 12 column (equilibrated and eluted as described above), and 0.5-ml fractions (collected anoxically) were monitored for VNFG by SDS-PAGE. When examining the interaction between FeV-co and VNFG, 200 µl of a solution of FeV-co was incubated with 200 µl of the VNFG-containing fraction for 20 min at room temperature, and 200 µl of the reaction mixture were applied to the Superose 12 column (equilibrated as described above). The column was developed, and fractions were collected as described above; the fractions were monitored for both FeV-co and VNFG by the FeV-co insertion assay and by SDS-PAGE, respectively.

In a control experiment, 200 µl of a solution of FeV-co were incubated with 200 µl (2.8 mg of protein) of cell-free extract of NH4+-grown UW45 (nifB-, conditions under which all three nitrogen fixing systems are repressed), and 200 µl of the reaction mixture were chromatographed as described above. Fractions were monitored for FeV-co using the FeV-co insertion assay. In a second control experiment, 200 µl of a solution of FeMo-co in NMF were chromatographed on the Superose 12 column both in the presence and absence of VNFG as described above; fractions were monitored for FeMo-co using the FeMo-co insertion assay (32) and for VNFG by SDS-PAGE.


RESULTS AND DISCUSSION

Accumulation of VNFG (delta ) in Various Mutant Backgrounds

The presence of VNFG was monitored in several A. vinelandii mutant strains by immunoblot analysis of cell-free extracts resolved by SDS-PAGE; Fig. 1 is an immunoblot of a SDS gel developed with antibody to VNFG. A. vinelandii strains CA12 (Delta nifHDK), CA117.30 (Delta nifDKB), and DJ42.48 (Delta nifENXvnfE) accumulated VNFG when the strains were grown and derepressed on V-containing medium (Fig. 1, lanes 1, 2, and 4). As reported previously, VNFG is a component of the apodinitrogenase 2 complex (33), and was detected in a purified sample of apodinitrogenase 2 (Fig. 1, lane 8). No VNFG was detected in extract of strain CA117.30 grown and derepressed on molybdenum-containing medium (Fig. 1, lane 5). As expected, strains CA11.1 (Delta nifHDKvnfDGK1::spc) and CA119 (vnfG, Cys-17 right-arrow stop) did not accumulate VNFG (Fig. 1, lanes 3 and 6); these data also show that the antibodies to VNFG did not cross-react with VNFDK (present in extract of strain CA119; Ref. 32).


Fig. 1. Accumulation of VNFG (the delta  protein) in various A. vinelandii strains. Immunoblot of an SDS gel developed with antibody to VNFG (0.12 mg of protein/lane). All strains were vnf-derepressed unless indicated otherwise. Lane 1, extract of CA12 (Delta nifHDK); lane 2, extract of CA117.30 (Delta nifDKB); lane 3, extract of CA11.1 (Delta nifHDKvnfDGK1::spc); lane 4, extract of DJ42.48 (Delta nifENXvnfE); lane 5, extract of nif-derepressed (vnf-repressed) CA117.30; lane 6, extract of CA119 (vnfG, Cys-17 right-arrow stop); lane 7, partially purified dinitrogenase 3; lane 8, purified apodinitrogenase 2.
[View Larger Version of this Image (29K GIF file)]


Interestingly, a low molecular weight protein in a partially purified fraction of the anf-encoded dinitrogenase 3 (purified from CA11.1 grown and derepressed on Mo- and V-deficient medium) was also detected with antibody to VNFG (Fig. 1, lane 7). The cross-reactive band seen in lane 7 was not VNFG since dinitrogenase 3 was partially purified from a strain containing a deletion in the vnfG gene (Fig. 1, lane 3); the low molecular weight protein detected was most likely ANFG, the delta  subunit of dinitrogenase 3. Given the 39.4% sequence identity at the amino acid level between ANFG and VNFG (1), it is not completely surprising that the antibody to VNFG is cross-reactive toward ANFG.

Characterization of Electrophoretically Distinct Species of VNFG (delta )

The forms of VNFG found in cell-free extracts were examined by anoxic native PAGE. Fig. 2A is an immunoblot of an anoxic native gel developed with antibody to VNFG, and shows the VNFG forms present in various extracts. For simplicity, the forms of VNFG, described below, are defined as the slow-migrating species A, and the fast-migrating species B (Fig. 2A). Species A consists of VNFG, which will be shown to be tightly associated with the VNFDK polypeptides; species B was determined to be a homodimer of VNFG. Accumulation of dinitrogenase 2 and apodinitrogenase 2 in the various extracts was monitored by the C2H2 reduction assay and the FeV-co insertion assay, respectively (Table I).


Fig. 2. Forms of VNFG accumulated in vivo. Immunoblot analysis of anoxic native gels (1.6 mg of protein/lane). Anoxic native gels were developed with antibody to VNFG (panel A) and with antibody to VNFDK (panel B). All strains were vnf-derepressed unless stated otherwise. Panel A, lane 1, extract of CA12 (Delta nifHDK); lane 2, extract of CA11.1 (Delta nifHDKvnfDGK1::spc); lane 3, extract of CA117.30 (Delta nifDKB); lane 4, extract of nif-derepressed (vnf-repressed) CA117.30; lane 5, extract of CA11.80 (Delta nifHDKvnfH); lane 6, extract of DJ42.48 (Delta nifENXvnfE); lane 7, extract of CA119 (vnfG, Cys-17 right-arrow stop). Species A consists of VNFG that is tightly associated with VNFDK polypeptides, and species B is a homodimer of VNFG protein. Panel B, lane 1, extract of CA12 (Delta nifHDK); lane 2, extract of CA11.1 (Delta nifHDKvnfDGK1::spc); lane 3, extract of CA117.30 (Delta nifDKB); lane 4, extract of CA11.80 (Delta nifHDKvnfH); lane 5, extract of DJ42.48 (Delta nifENXvnfE); lane 6, extract of nif-derepressed CA117.30.
[View Larger Version of this Image (30K GIF file)]


Table I.

Dinitrogenase 2 and apodinitrogenase 2 activities in extracts of various A. vinelandii strains


Straina Dinitrogenase 2b Apodinitrogenase 2b

nmol C2H4 formed/min/assay
CA12 (Delta nifHDK) 47.4 0.0
CA11.1 (Delta nifHDKvnfDGK) 0.0 0.0
CA117.30 (Delta nifDKB) 0.0 7.6
CA117.30 (nif-derepressed)c 0.0 0.0
CA11.80 (Delta nifHDKvnfH) 0.0 3.2
DJ42.48 (Delta nifENXvnfE) 0.0 6.8
CA119 (vnfG, Cys-17 right-arrow stop) 18.0 0.0

a  All strains were vnf-derepressed (see "Experimental Procedures") unless stated otherwise. Reactions contained 200 µl (3.8 mg of protein) of the appropriate cell-free extract.
b  Dinitrogenase 2 activity was monitored by the C2H2 reduction assay, and apodinitrogenase 2 activity was monitored by the FeV-co insertion assay (see "Experimental Procedures"). Activities are expressed as nmol of C2H4 formed/min/assay.
c  Strain CA117.30 was nif-derepressed as described under "Experimental Procedures."

Strain CA12 (Delta nifHDK) accumulated both VNFG species A and B (Fig. 2A, lane 1) and exhibited dinitrogenase 2 activity (Table I); no apodinitrogenase 2 was detected in the extracts by the FeV-co insertion assay; however, it is possible that a low level of apodinitrogenase 2 is present but cannot be estimated due to the high background activity of dinitrogenase 2 in the strain. The VNFDK polypeptides were shown to migrate to the position of VNFG species A by immunoblot analysis (using antibody to VNFDK) of extracts resolved by native PAGE (Fig. 2B). The antibodies to VNFDK did not cross-react with NIFDK (Fig. 2B, lane 6). Thus, VNFG species A in extract of CA12 constitutes VNFG associated with the VNFDK polypeptides via interactions that are not disrupted under conditions of the native PAGE procedure. The three forms of VNFG observed in species A (Fig. 2A, lane 1) most likely differ from each other in the stoichiometry of the VNFD, -G, and -K polypeptides in each form. Recently, Blanchard et al. reported the purification of two forms of dinitrogenase 2 from A. vinelandii: an alpha 2beta 2 form and an alpha beta 2 form; the delta  subunit was observed to be associated with both forms but was not quantitated (12).

Extracts of strains CA117.30 (Delta nifDKB), CA11.80 (Delta nifHDKvnfH), and DJ42.48 (Delta nifENXvnfE) exhibited VNFG species B only (Fig. 2A, lanes 3, 5, and 6) despite the presence of the VNFDK polypeptides in all three strains (Fig. 2B, lanes 3-5). All three strains exhibited apodinitrogenase 2 activity (as determined by the FeV-co insertion assay) but no dinitrogenase 2 activity (Table I). Therefore, a strain that accumulates dinitrogenase 2 contains both VNFG species A and B, whereas strains impaired in FeV-co biosynthesis that accumulate apodinitrogenase 2 exhibit only VNFG species B. Species B might result from the dissociation of VNFG from the alpha 2beta 2delta 2 apodinitrogenase 2 hexamer under the native PAGE and gel-filtration chromatography conditions; however, the possibility that a population of species B is not part of the apodinitrogenase 2 hexamer cannot be excluded. Species B observed in extract of CA12 might be due to the presence of low levels of apodinitrogenase 2. VNFG did not accumulate in strains CA11.1 (Delta nifHDKvnfDGK1::spc) and CA119 (vnfG, Cys-17 right-arrow stop), which contain lesions in vnfG (Fig. 2A, lanes 2 and 7).

Previously, we had determined that VNFG did not comigrate with VNFDK as a complex when purified apodinitrogenase 2 (alpha 2beta 2delta 2) was analyzed by anoxic native PAGE (24); it was also demonstrated that VNFG could be dissociated from VNFDK when apodinitrogenase 2 was chromatographed on a gel-filtration column (24). Thus, although the VNFDK and VNFG subunits copurified in a 1:1:1 ratio, suggesting (together with molecular mass analysis) that apodinitrogenase 2 is an alpha 2beta 2delta 2 hexamer (24), the weak interactions between VNFG (the delta  subunits) and VNFDK results in the dissociation of VNFG from the apodinitrogenase 2 hexamer under conditions of native PAGE and gel-filtration chromatography. In order to characterize VNFG species B, and to determine whether this species resulted from dissociation of VNFG from VNFDK, partially purified apodinitrogenase 2 (alpha 2beta 2delta 2) was analyzed by gel-filtration chromatography using a Superose 12 column (see "Experimental Procedures"). VNFG reproducibly exhibited an elution profile consistent with a molecular mass of ~26.3 kDa, which is approximately twice the predicted mass (13.8 kDa) for the vnfG gene product (19). Calibration of the Superose 12 column (see "Experimental Procedures") and the elution profile of VNFG from the Superose 12 column are indicated in Fig. 3A. VNFG in the Superose 12 fractions comigrated with VNFG species B in extract of strain CA12 (Delta nifHDK, vnf-derepressed) on an anoxic native gel (Fig. 3B, lanes 1-3). Thus, VNFG exists as a homodimer when it is not associated with the VNFDK polypeptides. VNFG in a sample of purified apodinitrogenase 2 (alpha 2beta 2delta 2) coelectrophoresed to the position of VNFG species B in cell-free extract of CA12 (Fig. 3, lanes 1 and 4), indicating that VNFG species B in cell-free extracts of the strains tested is a dimer that is not tightly associated with any other protein(s).


Fig. 3. Analysis of VNFG by Superose 12 gel-filtration chromatography. Panel A, elution profile of VNFG from the Superose 12 column. The calibration curve was made using bovine serum albumin, ovalbumin, myoglobin, and cytochrome c. The elution profile of VNFG was determined by a densitometry scan of a Coomassie-stained SDS gel of the Superose 12 fractions. The open squares denote the calibration curve, and the filled squares show the elution profile of VNFG. Panel B, immunoblot of an anoxic native gel developed with antibody to VNFG (~1.3 mg of protein/lane). Lane 1, extract of CA12 (Delta nifHDK, vnf-derepressed); lanes 2 and 3, VNFG-containing Superose 12 fractions; lane 4, purified apodinitrogenase 2. Species A consists of VNFG that is tightly associated with VNFDK polypeptides, and species B is a homodimer of VNFG protein.
[View Larger Version of this Image (21K GIF file)]


Although apodinitrogenase 2 was purified as an alpha 2beta 2delta 2 hexamer (24), the interactions between VNFG (delta ) and VNFDK (alpha beta ) appear to be readily disrupted under conditions of gel-filtration chromatography and native PAGE (24). In this respect, the physical properties of the alpha 2beta 2delta 2 apodinitrogenase 2 complex are quite distinct from those of the alpha 2beta 2gamma 2 form ofnif-encoded apodinitrogenase 1, since the gamma  protein comigrates with the alpha  and beta  subunits on native PAGE, and is dissociable only upon treatment of the alpha 2beta 2gamma 2 complex with reagents such as urea (37). Dinitrogenase 1 and 2 also differ from each other with respect to the affinities of the gamma  protein and VNFG for dinitrogenase 1 and 2, respectively. In cell-free extracts, the gamma  protein dissociates from the alpha 2beta 2gamma 2 apodinitrogenase 1 complex upon activation with FeMo-co (26), whereas the delta  subunits (VNFG) became tightly associated with the alpha  and beta  subunits of dinitrogenase 2 in the presence of FeV-co (Fig. 2A, lane 1; results discussed below).

Requirements for the Stable Association of VNFG (delta ) with VNFDK (alpha beta )

The in vitro FeV-co insertion assay system together with anoxic native PAGE was employed to investigate conditions under which VNFG species B would associate stably with VNFDK to form species A (VNFG tightly associated with VNFDK). In vitro FeV-co insertion reactions from which components were excluded, one at a time or in combination, were applied onto the native gel, and the VNFG species accumulated in the various reactions were compared to those accumulated in a complete FeV-co insertion reaction (see "Experimental Procedures"). Fig. 4 is an immunoblot of an anoxic native gel (developed with antibody to VNFG) that illustrates the requirements for the stable association of VNFG with VNFDK. Cell-free extract (desalted by Sephadex G-25 chromatography) of strain CA117.30 (Delta nifDKB) was used as a source of apodinitrogenase 2 in the FeV-co insertion assays. Extract of strain CA12 (Delta nifHDK), which exhibited dinitrogenase 2 activity (Fig. 4, lane 1), shows the presence of both VNFG species A (VNFG tightly associated with VNFDK) and B (dimer of VNFG). A FeV-co insertion reaction that excluded both FeV-co and the ATP-regenerating mixture (defined in "Experimental Procedures") exhibited VNFG species B, the form exhibited by all strains containing apodinitrogenase 2 (Fig. 4, lane 2). Upon addition of FeV-co to a reaction that excluded only the ATP-regenerating mixture, the formation of VNFG species A was observed (Fig. 4, lane 3). The level of VNFG species A formed was increased in a complete FeV-co insertion reaction (Fig. 4, lane 4) in comparison to the reaction that excluded the ATP-regenerating mixture (Fig. 4, lane 3).


Fig. 4. Immunoblot (developed with antibody to VNFG) of an anoxic native gel of various FeV-co insertion reactions. All strains were vnf-derepressed. See "Experimental Procedures" for components included in a complete FeV-co insertion reaction. Desalted extract of CA117.30 (Delta nifDKB) was used as a source of apodinitrogenase 2. Lane 1, extract of CA12 (Delta nifHDK) alone; lane 2, minus FeV-co and MgATP reaction; lane 3, minus MgATP reaction; lane 4, complete FeV-co insertion reaction; lane 5, minus FeV-co reaction; lane 6, minus apodinitrogenase 2 (CA117.30 extract) reaction; lane 7, complete reaction with FeMo-co added in place of FeV-co. Table below figure indicates components added to reaction mixture (+). C2H2 reduction activities (see "Experimental Procedures") of the reactions (0.6-1.8 mg of protein) are indicated (nmol of C2H4 formed/min/assay). Species A consists of VNFG that is tightly associated with VNFDK polypeptides, and species B is a homodimer of VNFG protein.
[View Larger Version of this Image (31K GIF file)]


The appearance of species A can be correlated with the formation of holodinitrogenase 2 in the reactions that were tested in the C2H2 reduction assay (see "Experimental Procedures"); the dinitrogenase 2 activity indicated in lane 3 where the ATP-regenerating mixture was excluded from the FeV-co insertion reaction applied onto the native gel is probably due to the addition of excess ATP-regenerating mixture to all the reactions that were monitored for C2H2 reduction activity (see "Experimental Procedures"). When FeV-co was oxidized by exposure to air prior to its addition to the FeV-co insertion reaction, formation of species A was not observed (data not shown). Thus, the presence of FeV-co that is able to reconstitute apodinitrogenase 2 to active dinitrogenase 2 promotes the association of VNFG with VNFDK, and the association is stimulated by the addition of the ATP-regenerating mixture to the FeV-co insertion assay. The stable association of VNFG with VNFDK might arise from a conformational change (induced in the apodinitrogenase 2 complex upon insertion of FeV-co into the active site) that increases the affinity of VNFG for VNFDK; alternatively, VNFG might function in associating with and inserting FeV-co into the active site of apodinitrogenase 1, upon which VNFG forms a stable complex with VNFDK. The latter possibility is addressed in a later section. It is worth noting that, although the desalted extracts of CA117.30 (Delta nifDKB) used in this particular study contained high levels of dinitrogenase reductase 2, use of partially purified apodinitrogenase 2 (and also extract of strain CA11.80 (Delta nifHDKvnfH)) free of dinitrogenase reductase 2 in later studies indicated that dinitrogenase reductase 2 is not necessary for the association of VNFG with VNFDK (discussed below).

The level of species A formed in the absence of added ATP-regenerating mixture (to reactions analyzed by native PAGE) during the insertion phase of the assay (see "Experimental Procedures") is most likely due the incomplete removal of nucleotides from the cell-free extract by Sephadex G-25 chromatography; the requirement of nucleotide in the stable association of VNFG with VNFDK was investigated further, and the results are discussed below. When FeV-co was excluded from the insertion reaction, the formation of species A was not observed (Fig. 4, lane 5), indicating that the presence of the ATP-regenerating mixture alone does not promote the association of VNFG with VNFDK. As anticipated, when extract of CA117.30 (Delta nifDKB), the source of alpha 2beta 2delta 2 apodinitrogenase 2 was excluded from the FeV-co insertion assay, no VNFG was observed (Fig. 4, lane 6).

The observation that the addition of FeMo-co (in place of FeV-co) to the insertion reaction did not promote the stable association of VNFG with VNFDK was surprising (Fig. 4, lane 7). Activation of apodinitrogenase 2 with FeMo-co results in the formation of a hybrid dinitrogenase 2 that exhibits low levels of C2H2 reduction activity (Ref. 33; see also Fig. 4, lane 7). It is possible that the activation of apodinitrogenase 2 by FeMo-co is inefficient, and therefore the level of species A formed is below the detection limit of the visualization method used. The level of FeMo-co added to the insertion reaction was sufficient to activate apodinitrogenase 1 in extract of A. vinelandii strain UW45 (nifB-) to a high level (27.8 nmol of C2H4 formed/min/assay); thus, the absence of species A is not a result of a limiting amount of FeMo-co. When FeMo-co was added to the insertion reaction in the form of acid-denatured dinitrogenase 1 (instead of purified FeMo-co in NMF), species A formation was still not observed (data not shown), indicating that its absence is not a result of any denaturing effects of NMF. A second possibility that could account for the absence of species A formation in the presence of FeMo-co is that VNFG might be involved in specifically associating with FeV-co but not FeMo-co, and inserting the cofactor into the active site pocket of apodinitrogenase 2. This possibility is supported in part by studies described below.

The Requirement of Nucleotide in the Association of VNFG with VNFDK

In order to determine whether nucleotide was absolutely required for the association of VNFG with VNFDK, partially purified apodinitrogenase 2 was used in place of desalted, cell-free extract of CA117.30 in the FeV-co insertion assay. Fig. 5 is an immunoblot of an anoxic native gel (developed with antibody to VNFG) that illustrates the results of this study. In the absence of both FeV-co and nucleotide, species A was not observed (Fig. 5, lane 1). The addition of FeV-co alone to a reaction that excluded nucleotide did not promote association of VNFG with VNFDK (Fig. 5, lane 2). ATP and its analogs ADP and beta ,gamma -CH2-ATP functioned in the formation of species A (Fig. 5, lanes 4-6). These data demonstrate that both FeV-co and nucleotide are necessary for the stable association of VNFG with VNFDK. When the components of the ATP-regenerating system excluding ATP were added to a FeV-co insertion reaction, species A formation did not occur (Fig. 5, lane 3), indicating that Mg2+, creatine phosphate, and creatine phosphokinase were not responsible for the stable association of VNFG with VNFDK.


Fig. 5. Immunoblot (developed with antibody to VNFG) of an anoxic native gel of FeV-co insertion reactions with various nucleotides. Partially purified apodinitrogenase 2 was used in these reactions in place of desalted cell extracts. Lane 1, minus FeV-co and MgATP reaction; lane 2, minus MgXTP reaction; lane 3, minus XTP reaction; lane 4, complete reaction containing ATP; lane 5, complete reaction containing ADP; lane 6, complete reaction containing beta ,gamma -CH2- ATP. Table below figure indicates components added to reaction mixture (+).
[View Larger Version of this Image (40K GIF file)]


An interesting observation that arose from these studies was that dinitrogenase reductase appeared not to be necessary for the stable association of VNFG with VNFDK. The partially purified fraction of apodinitrogenase 2 used in the FeV-co insertion reactions contained no dinitrogenase reductase 1 (or dinitrogenase reductase 2) as detected by C2H2 reduction activity when complemented with dinitrogenase 1, and also by immunoblot analysis of the fraction using antibody to dinitrogenase reductase 1 (dinitrogenase reductase 2 can be detected by antibody to dinitrogenase reductase 1; data not shown). Dinitrogenase reductase 1 or dinitrogenase reductase 2 were included in certain FeV-co insertion reactions to determine whether an effect on species A formation would be observed in their presence. Reactions in which dinitrogenase reductase 1 or dinitrogenase reductase 2 were added in the absence of FeV-co did not result in species A formation (data not shown), indicating that the presence of dinitrogenase reductase and ATP (added in the form of an ATP-regenerating system) were insufficient for the stable association of VNFG with VNFDK. In a complete FeV-co insertion reaction (containing FeV-co), addition of dinitrogenase reductase 1 or dinitrogenase reductase 2 did not have an effect on the association of VNFG with VNFDK (data not shown).

The requirements for the stable association of VNFG with the VNFDK polypeptides of apodinitrogenase 2 differ in two notable aspects from the processing of alpha 2beta 2 (NIFDK) apodinitrogenase 1 to the alpha 2beta 2gamma 2 form of apodinitrogenase 1: 1) FeV-co is required for the former process whereas the presence of FeMo-co is not necessary for the association of the gamma  protein with the NIFDK polypeptides of apodinitrogenase 1 (25), and 2) dinitrogenase reductase is not required for the stable association of VNFG with VNFDK; Allen et al. (25) demonstrated the requirement of dinitrogenase reductase 1 (NIFH) in the formation of the alpha 2beta 2gamma 2 apodinitrogenase 1 complex. Both of the above processes are nucleotide-requiring; however, association of gamma  with alpha 2beta 2 apodinitrogenase 1 requires ATP (25), a non-hydrolyzable analog of ATP did not support the maturation process.2 The precise roles of dinitrogenase reductase 1 and nucleotide in the maturation of apodinitrogenase 1 have not been established. The stable association of VNFG with VNFDK is supported by ATP and its analogs ADP and beta ,gamma -CH2-ATP (a non-hydrolyzable analog of ATP), suggesting that the hydrolysis of ATP might not be necessary for the process. A number of functions might be proposed for the nucleotide in the FeV-co-dependent association of VNFG with VNFDK. Upon insertion of FeV-co into apodinitrogenase 2, nucleotide might be necessary for maintaining a certain conformational state that allows the stable association of VNFG with VNFDK. Alternatively, nucleotide might be necessary for the insertion of FeV-co into apodinitrogenase 2 to form the holoenzyme, or for the formation of a VNFG-FeV-co complex. The latter possibility can most likely be ruled out as the association of FeV-co with VNFG in vitro does not require the addition of nucleotide (discussed further below).

In Vitro Association of FeV-co with VNFG (the delta  Protein)

The interaction between FeV-co and VNFG was examined by gel-filtration chromatography. A FeV-co-containing solution and a VNFG-containing fraction (that contained no VNFDK and thus exhibited no activity in the FeV-co insertion assay) were fractionated separately on a calibrated Superose 12 column (see "Experimental Procedures"). VNFG reproducibly eluted at Ve/Vo 1.65-1.82 (Fig. 3A), and FeV-co eluted at Ve/Vo 1.06-1.24 (Fig. 6A, peak 1), most likely because the cofactor remained associated with the acid-denatured dinitrogenase 2 protein (which is predicted to elute at approximately Vo).


Fig. 6. Association of FeV-co with VNFG (the delta  protein) in vitro. Panel A, elution profile of FeV-co from the Superose 12 column in the absence (peak 1) and presence (peak 2) of VNFG (determined in separate experiments). The FeV-co insertion assay was used to monitor the presence of FeV-co. Panel B, SDS-PAGE analysis of the FeV-co-containing fractions in peak 2. Lane 1, molecular size standards; lanes 2-5, Superose 12 fractions containing FeV-co. The arrow indicates the position of VNFG. Panel C, elution profile of FeV-co from the Superose 12 column in the absence (peak 1) and presence (peak 2) of NH4+-grown UW45 (nifB-) extract (separate experiments). Panel D, elution profile of FeMo-co from the Superose 12 column in the absence (peak 1) and presence (peak 2) of VNFG (separate experiments). The presence of FeMo-co was monitored by the FeMo-co insertion assay as described in Ref. 12. The squares denote the elution profile of FeV-co (or FeMo-co) in the absence of added VNFG; the circles denote the elution profile of FeV-co (or FeMo-co) in the presence of VNFG. Species A consists of VNFG that is tightly associated with VNFDK polypeptides, and species B is a homodimer of VNFG protein.
[View Larger Version of this Image (24K GIF file)]


When a reaction mixture containing both the FeV-co-containing solution and the VNFG-containing fraction was chromatographed on the Superose 12 column, the migration of FeV-co was retarded; FeV-co eluted at Ve/Vo 1.59-1.76 (Fig. 6A, peak 2). The Superose 12 fractions that contained FeV-co (as determined by the FeV-co insertion assay) were analyzed by SDS-PAGE, and the presence of VNFG in these fractions was demonstrated (Fig. 6B, lanes 2-5). When the FeV-co-containing Superose 12 fractions were added to apodinitrogenase 2 (in extracts of CA117.30 (Delta nifDKB)), the formation of holodinitrogenase 2 was observed (data not shown). Upon fractionation of a mixture containing both the FeV-co solution and extract of strain UW45 ((nifB-), grown under NH4+-sufficient conditions) on the Superose 12 column, the migration of FeV-co remained unaltered (Fig. 6C, peaks 1 and 2), suggesting that the change in the elution profile of FeV-co upon addition to VNFG is quite likely due to a specific interaction of FeV-co with VNFG.

In a similar set of experiments performed using FeMo-co in place of FeV-co, the elution profile of FeMo-co remained unaffected in the presence of added VNFG (Fig. 6D, peaks 1 and 2), further suggesting that VNFG associates specifically with FeV-co. These data, together with the apparently reversible association of VNFG with the apodinitrogenase 2 complex, suggest that VNFG might function in binding and inserting FeV-co into apodinitrogenase 2 to form the holoenzyme.

Two A. vinelandii strains were examined for the in vivo accumulation of FeV-co, strain CA11.6.82 (W-tolerant, vnfD82:: Tn5B21Delta nifHDKrifr) and strain CA11.1 (Delta nifHDKvnfDGK1:: spc). FeV-co was not detected in extracts of these strains (vnf-derepressed) by the FeV-co insertion assay. Given the in vitro data suggesting the specific association of FeV-co with VNFG, it is reasonable to expect that detectable levels FeV-co might accumulate in vivo only in the presence of VNFG; extracts of both strains tested lacked VNFG (as determined by immunoblot analysis using antibody to VNFG). In contrast to the nif system, in which the dinitrogenase 1 polypeptides are not required for the synthesis and accumulation of FeMo-co (38, 39), the presence of the dinitrogenase 2 polypeptides might be necessary for the accumulation of detectable levels of FeV-co. The possibility that FeV-co is assembled on the dinitrogenase 2 polypeptides cannot be excluded. The fact that no FeV-co was observed to accumulate in vivo in strains CA11.1 (Delta nifHDKvnfDGK1::spc) and CA11.6.82 (W-tolerant, vnfD82::Tn5B21Delta nifHDKrifr), despite the presence of significant levels of the gamma  protein (as detected by immunoblot analysis) in extracts of both strains, suggests that the gamma  protein is not able to function as a chaperone-insertase in the nitrogenase 2 enzyme system.

Based on our prior (24) and current observations, a model for the formation of holodinitrogenase 2 can be proposed (Fig. 7). Two processes could lead to the association of VNFG with FeV-co. 1) In the presence of FeV-co, the loosely associated VNFG (delta ) subunits of the alpha 2beta 2delta 2 apodinitrogenase 2 complex might dissociate (and dimerize) and bind FeV-co; or 2) a VNFG dimer that is not a part of the apodinitrogenase 2 hexamer might associate with FeV-co. The in vitro association of FeV-co with the VNFG dimer does not require the presence of nucleotide; however, nucleotide is required for the stable association of VNFG with VNFDK. Thus, in a subsequent nucleotide-dependent process, the VNFG-FeV-co species could donate FeV-co to apodinitrogenase 2, inducing a conformational change in the overall quaternary structure of the complex that allows the stable association of VNFG with the newly reconstituted dinitrogenase 2. The fact that VNFG remains stably associated with VNFDK polypeptides in holodinitrogenase 2 might have implications for its role in catalysis; studies of Waugh et al. (23) indicated that VNFG was required for full catalytic activity of nitrogenase 2. 


Fig. 7. A model for the formation of dinitrogenase 2. The open squares represent empty FeV-co sites in the alpha  subunit of apodinitrogenase 2, and the boxed "P" represent the P clusters.
[View Larger Version of this Image (22K GIF file)]


The association of FeV-co with VNFG might be further characterized by monitoring the ability of altered forms of VNFG to bind FeV-co. The predicted amino acid sequence of VNFG indicates the presence of a single cysteine residue that is conserved between both VNFG and ANFG (the third subunit of dinitrogenase 3). By analogy to the role of Cys-275 of dinitrogenase 1 (one of the ligands to FeMo-co; Ref. 22), the invariant cysteine residue of VNFG (Cys-17) might serve as a ligand to FeV-co. It will be interesting to site-specifically alter Cys-17 of VNFG, and study the effect of the mutation(s) on the ability of VNFG to associate with FeV-co both in vivo and in vitro.


CONCLUSIONS

In this study, we have characterized the forms of VNFG observed in cell-free extracts of various A. vinelandii mutant strains, and correlated the VNFG forms with the presence of either apodinitrogenase 2 or holodinitrogenase 2. The homodimeric form of VNFG observed under native PAGE and gel-filtration chromatography conditions in extracts of strains that accumulate apodinitrogenase 2 most likely results from VNFG dissociating from the alpha 2beta 2delta 2 apodinitrogenase 2 complex due to weak interactions of VNFG with VNFDK. In the presence of FeV-co and nucleotide, VNFG becomes associated stably with the VNFDK polypeptides to yield the VNFG form observed in strains that accumulate dinitrogenase 2. In addition, the stable association of VNFG with VNFDK can be correlated with the formation of catalytically active dinitrogenase 2. In vitro, FeV-co associates with the dimeric form of VNFG (in the absence of nucleotide), and combination of this VNFG-FeV-co species with apodinitrogenase 2 results in its activation to the holoenzyme. These data suggest that VNFG has a role in the formation of dinitrogenase 2. The differences that have emerged between the modes of action of VNFG and the gamma  protein illustrate that the mechanisms utilized in the processing of apodinitrogenase 2 to a catalytically active form are clearly distinct from those involved in the maturation of apodinitrogenase 1.


FOOTNOTES

*   This research was supported in part by United States Department of Agriculture NRI Grant 9603313. The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Dagger    To whom correspondence should be addressed. Tel.: 608-262-6859; Fax: 608-262-3453; E-mail: ludden{at}biochem.wisc.edu.
§   Supported by National Institutes of Health Grant GM35332 (to P. W. L.).
1    The abbreviations used are: FeV-co, iron-vanadium cofactor; FeMo-co, iron-molybdenum cofactor; DTH, sodium dithionite; PAGE, polyacrylamide gel electrophoresis; NMF, N-methylformamide.
2   M. J. Homer and G. P. R. Roberts, personal communication.

Acknowledgments

We thank Ronda Allen and Gary Roberts for valuable discussions and for critically reading this manuscript. We also thank Paul Bishop and R. Premakumar for generously providing A. vinelandii mutant strains and for helpful discussions. We acknowledge Stefan Nordlund for insightful comments.


REFERENCES

  1. Bishop, P. E., and Joerger, R. D. (1990) Annu. Rev. Plant Physiol. Plant Mol. Biol. 41, 109-125 [CrossRef]
  2. Eady, R. R. (1991) Adv. Inorg. Chem. 36, 77-102
  3. Luque, F., and Pau, R. N. (1991) Mol. Gen. Genet. 227, 481-487 [Medline] [Order article via Infotrieve]
  4. Joerger, R. D., Premakumar, R., and Bishop, P. E. (1986) J. Bacteriol. 168, 673-682 [Medline] [Order article via Infotrieve]
  5. Kennedy, C., Gamal, R., Humphrey, R., Ramos, J., Brigle, K., and Dean, D. R. (1986) Mol. Gen. Genet. 205, 318-325
  6. Kennedy, C., and Dean, D. (1992) Mol. Gen. Genet. 231, 494-498 [Medline] [Order article via Infotrieve]
  7. Dean, D. R., Bolin, J. T., and Zheng, L. (1993) J. Bacteriol. 175, 6737-6744 [Medline] [Order article via Infotrieve]
  8. Howard, J. B., and Rees, D. C. (1994) Annu. Rev. Biochem. 63, 235-264 [CrossRef][Medline] [Order article via Infotrieve]
  9. Smith, B. E., and Eady, R. R. (1992) Eur. J. Biochem. 205, 1-15 [Medline] [Order article via Infotrieve]
  10. Hales, B. J., Langosch, D. J., and Case, E. E. (1986) J. Biol. Chem. 261, 15301-15306 [Abstract/Free Full Text]
  11. Hales, B. J., Case, E. E., Morningstar, J. E., Dzeda, M. F., and Mauterer, L. A. (1986) Biochemistry 25, 7251-7255 [Medline] [Order article via Infotrieve]
  12. Blanchard, C. Z., and Hales, B. J. (1996) Biochemistry 35, 472-478 [CrossRef][Medline] [Order article via Infotrieve]
  13. Robson, R. L., Eady, R. R., Richardson, T. H., Miller, R. W., Hawkins, M., and Postgate, J. R. (1986) Nature 322, 388-390
  14. Eady, R. R., Robson, R. L., Richardson, T. H., Miller, R. W., and Hawkins, M. (1987) Biochem. J. 244, 197-207 [Medline] [Order article via Infotrieve]
  15. Smith, B. E., Eady, R. R., Lowe, D. J., and Gormal, C. (1988) Biochem. J. 250, 299-302 [Medline] [Order article via Infotrieve]
  16. Ravi, N., Moore, V., Lloyd, S. G., Hales, B. J., and Huynh, B. H. (1994) J. Biol. Chem. 269, 20920-20924 [Abstract/Free Full Text]
  17. Allen, R. M., Chatterjee, R., Madden, M. S., Ludden, P. W., and Shah, V. K. (1994) Crit. Rev. Biotechnol. 14, 225-249 [Medline] [Order article via Infotrieve]
  18. Fallik, E., Chan, Y. K., and Robson, R. L. (1991) J. Bacteriol. 173, 365-371 [Medline] [Order article via Infotrieve]
  19. Joerger, R. D., Loveless, T. M., Pau, R. N., Mitchenall, L. A., Simon, B. H., and Bishop, P. E. (1990) J. Bacteriol. 172, 3400-3408 [Medline] [Order article via Infotrieve]
  20. Robson, R. L., Woodley, P. R., Pau, R. N., and Eady, R. R. (1989) EMBO J. 8, 1217-1224 [Abstract]
  21. Joerger, R. D., Jacobson, M. R., Premakumar, R., Wolfinger, E. D., and Bishop, P. E. (1989) J. Bacteriol. 171, 1075-1086 [Medline] [Order article via Infotrieve]
  22. Kim, J. S., and Rees, D. C. (1992) Nature 360, 553-560 [CrossRef]
  23. Waugh, S. I., Paulsen, D. M., Mylona, P. V., Maynard, R. H., Premakumar, R., and Bishop, P. E. (1995) J. Bacteriol. 177, 1505-1510 [Abstract]
  24. Chatterjee, R., Allen, R. M., Ludden, P. W., and Shah, V. K. (1996) J. Biol. Chem. 271, 6819-6826 [Abstract/Free Full Text]
  25. Allen, R. M., Homer, M. J., Chatterjee, R., Ludden, P. W., Roberts, G. P., and Shah, V. K. (1993) J. Biol. Chem. 268, 23670-23674 [Abstract/Free Full Text]
  26. Homer, M. J., Dean, D. R., and Roberts, G. P. (1995) J. Biol. Chem. 270, 24745-24752 [Abstract/Free Full Text]
  27. Bishop, P. E., Premakumar, R., Dean, D. R., Jacobson, M. R., Chisnell, J. R., Rizzo, T. M., and Kopzcynski, J. (1985) Science 232, 92-94
  28. Chisnell, J. R., Premakumar, R., and Bishop, P. E. (1988) J. Bacteriol. 170, 27-33 [Medline] [Order article via Infotrieve]
  29. Wolfinger, E. D., and Bishop, P. E. (1991) J. Bacteriol. 173, 7565-7572 [Medline] [Order article via Infotrieve]
  30. Premakumar, R., Jacobitz, S., Ricke, S. C., and Bishop, P. E. (1996) J. Bacteriol. 178, 691-696 [Abstract]
  31. Shah, V. K., Imperial, J., Ugalde, R. A., Ludden, P. W., and Brill, W. J. (1986) Proc. Natl. Acad. Sci. U. S. A. 83, 1636-1640 [Abstract]
  32. Shah, V. K., and Brill, W. J. (1977) Proc. Natl. Acad. Sci. U. S. A. 74, 3249-3253 [Abstract]
  33. O'Farrell, P. H. (1975) J. Biol. Chem. 250, 4007-4021 [Abstract]
  34. Brandner, J. P., McEwan, A. G., Kaplan, S., and Donahue, T. (1989) J. Bacteriol. 171, 360-368 [Medline] [Order article via Infotrieve]
  35. Allen, R. M., Chatterjee, R., Ludden, P. W., and Shah, V. K. (1996) J. Biol. Chem. 271, 4256-4260 [Abstract/Free Full Text]
  36. Smith, P. K., Krohn, R. I., Hermanson, A. K., Mallia, A. K., Gartner, F. H., Provenzano, M. D., Fujimoto, E. K., Goeke, N. M., Olson, B. J., and Klenk, D. C. (1985) Anal. Biochem. 150, 76-85 [Medline] [Order article via Infotrieve]
  37. Paustian, T. D., Shah, V. K., and Roberts, G. P. (1990) Biochemistry 29, 3515-3522 [Medline] [Order article via Infotrieve]
  38. Imperial, J., Shah, V. K., Ugalde, R. A., Ludden, P. W., and Brill, W. J. (1987) J. Bacteriol. 169, 1784-1786 [Medline] [Order article via Infotrieve]
  39. Ugalde, R. A., Imperial, J., Shah, V. K., and Brill, W. J. (1984) J. Bacteriol. 159, 888-893 [Medline] [Order article via Infotrieve]

©1997 by The American Society for Biochemistry and Molecular Biology, Inc.